Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPO,Erythropoietin,Wald ratio,1,0.86 [0.82-0.91],1.40018912474148e-07,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COL9A1,Collagen alpha-1(IX) chain,Wald ratio,1,1.14 [1.08-1.2],1.92215517700933e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CDH2,Cadherin-2,Wald ratio,1,1.12 [1.07-1.18],6.49360750659356e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Wald ratio,1,1.09 [1.05-1.13],2.08847413414078e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CDH15,Cadherin-15,Wald ratio,1,1.1 [1.05-1.15],5.21069942602923e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BTN3A2,Butyrophilin subfamily 3 member A2,Wald ratio,1,1.12 [1.06-1.18],5.8039529074601e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ICAM1,Intercellular adhesion molecule 1,Wald ratio,1,1.11 [1.05-1.16],7.26788680631369e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD5,T-cell surface glycoprotein CD5,Wald ratio,1,1.11 [1.05-1.17],9.54121220292748e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DDR1,Epithelial discoidin domain-containing receptor 1,Wald ratio,1,1.11 [1.05-1.17],0.000102926439822022,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Wald ratio,1,1.11 [1.05-1.17],0.000142850025699211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD48,CD48 antigen,Wald ratio,1,1.09 [1.04-1.15],0.000236909593973789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ICAM5,Intercellular adhesion molecule 5,Wald ratio,1,1.08 [1.04-1.13],0.000292319932491091,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC5A,C-type lectin domain family 5 member A,Wald ratio,1,1.1 [1.04-1.16],0.000347161740936371,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.1 [1.04-1.16],0.000487804001431289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PLAUR,Urokinase plasminogen activator surface receptor,Wald ratio,1,1.1 [1.04-1.16],0.000575585889562063,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GUCA2A,Guanylin,Wald ratio,1,1.09 [1.04-1.15],0.000945536654341123,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CHRDL1,Chordin-like protein 1,Wald ratio,1,1.09 [1.03-1.14],0.000959439397168251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.92 [0.87-0.97],0.00120967808289876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DSC2,Desmocollin-2,Wald ratio,1,1.09 [1.03-1.15],0.00139873684219389,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PDCD1,Programmed cell death protein 1,Wald ratio,1,1.08 [1.03-1.14],0.00283424216875458,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ALCAM,CD166 antigen,Wald ratio,1,1.08 [1.03-1.13],0.00305119917088709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPINT1,Kunitz-type protease inhibitor 1,Wald ratio,1,1.08 [1.03-1.14],0.00312585735171282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,QPCT,Glutaminyl-peptide cyclotransferase,Wald ratio,1,1.08 [1.03-1.14],0.00334999152022473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NRP2,Neuropilin-2,Wald ratio,1,1.08 [1.03-1.14],0.00360902606975297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SEPTIN8,Septin-8,Wald ratio,1,1.08 [1.03-1.14],0.0036725251337635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PILRB,Paired immunoglobulin-like type 2 receptor beta,Wald ratio,1,1.06 [1.02-1.1],0.00376828550667035,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NCR1,Natural cytotoxicity triggering receptor 1,Wald ratio,1,1.08 [1.02-1.14],0.00486357893425337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Wald ratio,1,1.08 [1.02-1.14],0.00502765223628377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HYAL1,Hyaluronidase-1,Wald ratio,1,0.93 [0.88-0.98],0.00588862343266877,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD300LF,CMRF35-like molecule 1,Wald ratio,1,1.05 [1.02-1.09],0.00596705723561034,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCARB2,Lysosome membrane protein 2,Wald ratio,1,1.07 [1.02-1.13],0.006725597580701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PCDH17,Protocadherin-17,Wald ratio,1,1.07 [1.02-1.13],0.00683149532696216,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.08 [1.02-1.14],0.00697998341366421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CDH1,Cadherin-1,Wald ratio,1,1.07 [1.02-1.13],0.00839218485315411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,REN,Renin,Wald ratio,1,0.93 [0.89-0.98],0.00880337482483098,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Wald ratio,1,1.07 [1.02-1.12],0.00923203341488674,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Wald ratio,1,1.06 [1.01-1.1],0.0101758501372485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LTBR,Tumor necrosis factor receptor superfamily member 3,Wald ratio,1,1.07 [1.02-1.13],0.0109181160946862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC7A,C-type lectin domain family 7 member A,Wald ratio,1,1.06 [1.01-1.1],0.0110386224035348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.07 [1.02-1.13],0.0111181713204033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VSIG2,V-set and immunoglobulin domain-containing protein 2,Wald ratio,1,1.07 [1.02-1.13],0.011176328246681,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL1R1,Interleukin-1 receptor type 1,Wald ratio,1,1.07 [1.02-1.13],0.0116926193186256,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Wald ratio,1,1.07 [1.01-1.13],0.0120946213325923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD14,Monocyte differentiation antigen CD14,Wald ratio,1,1.07 [1.01-1.13],0.0125389142989004,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PLA2G15,Phospholipase A2 group XV,Wald ratio,1,0.94 [0.89-0.99],0.0129561108453541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BMPER,BMP-binding endothelial regulator protein,Wald ratio,1,1.07 [1.01-1.13],0.0133038674811668,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Wald ratio,1,1.07 [1.01-1.13],0.014128255147484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,XCL1,Lymphotactin,Wald ratio,1,1.06 [1.01-1.11],0.0143701727802202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EFNA4,Ephrin-A4,Wald ratio,1,1.07 [1.01-1.13],0.0150184138470457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Wald ratio,1,1.06 [1.01-1.11],0.0150800881296611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD80,T-lymphocyte activation antigen CD80,Wald ratio,1,1.06 [1.01-1.12],0.0152670485512459,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Wald ratio,1,1.06 [1.01-1.12],0.015550627404689,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PGA4,Pepsin A-4,Wald ratio,1,1.07 [1.01-1.13],0.0161289473801438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BSG,Basigin,Wald ratio,1,1.07 [1.01-1.12],0.0168085513951852,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TFF2,Trefoil factor 2,Wald ratio,1,1.07 [1.01-1.12],0.0174017540776075,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Wald ratio,1,1.06 [1.01-1.12],0.0177894261633147,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Wald ratio,1,1.07 [1.01-1.13],0.0178834598204602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD27,CD27 antigen,Wald ratio,1,1.07 [1.01-1.12],0.0179911593740081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RNF149,E3 ubiquitin-protein ligase RNF149,Wald ratio,1,1.07 [1.01-1.12],0.0202571176365055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CSF1,Macrophage colony-stimulating factor 1,Wald ratio,1,1.07 [1.01-1.12],0.0202769433818823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IFNGR1,Interferon gamma receptor 1,Wald ratio,1,1.07 [1.01-1.12],0.0207815439666492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIRPB1,Signal-regulatory protein beta-1,Wald ratio,1,1.05 [1.01-1.1],0.0216184141645597,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DLL1,Delta-like protein 1,Wald ratio,1,1.06 [1.01-1.12],0.0247798828389925,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NPL,N-acetylneuraminate lyase,Wald ratio,1,1.06 [1.01-1.11],0.0248508062081398,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,1.06 [1.01-1.12],0.0276997718217715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SFRP1,Secreted frizzled-related protein 1,Wald ratio,1,0.94 [0.9-0.99],0.0286126896159902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TINAGL1,Tubulointerstitial nephritis antigen-like,Wald ratio,1,1.06 [1.01-1.12],0.0303811270904227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PIGR,Polymeric immunoglobulin receptor,Wald ratio,1,1.06 [1-1.12],0.0325408088695213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Wald ratio,1,1.06 [1-1.11],0.0349081666097387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Wald ratio,1,0.95 [0.9-1],0.0360679577913205,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MFGE8,Lactadherin,Wald ratio,1,1.06 [1-1.11],0.0362942475780332,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD160,CD160 antigen,Wald ratio,1,1.06 [1-1.11],0.0392708323775057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CANT1,Soluble calcium-activated nucleotidase 1,Wald ratio,1,1.06 [1-1.12],0.039634325202296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPP1,Osteopontin,Wald ratio,1,1.06 [1-1.11],0.0401037222292511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GSN,Gelsolin,Wald ratio,1,0.95 [0.9-1],0.0419387623536504,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AMBP,Protein AMBP,Wald ratio,1,1.06 [1-1.11],0.0421339445791112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD79B,B-cell antigen receptor complex-associated protein beta chain,Wald ratio,1,1.06 [1-1.11],0.0430024832121642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CTSV,Cathepsin L2,Wald ratio,1,0.95 [0.9-1],0.045181026740895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TIMP1,Metalloproteinase inhibitor 1,Wald ratio,1,1.06 [1-1.11],0.0456406178533548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Wald ratio,1,1.05 [1-1.11],0.0472071946925078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.05 [1-1.11],0.0482718091263593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PTN,Pleiotrophin,Wald ratio,1,0.95 [0.9-1],0.0498614429357446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL11,Eotaxin,Wald ratio,1,1.05 [1-1.11],0.0500505076799427,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CHGA,Chromogranin-A,Wald ratio,1,1.05 [1-1.11],0.0503589154010197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CTSD,Cathepsin D,Wald ratio,1,1.05 [1-1.11],0.05140830936348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Wald ratio,1,1.05 [1-1.1],0.0519425576395084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CAPG,Macrophage-capping protein,Wald ratio,1,1.04 [1-1.09],0.0540252513377632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL18BP,Interleukin-18-binding protein,Wald ratio,1,1.05 [1-1.11],0.0552973119340558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LAMP3,Lysosome-associated membrane glycoprotein 3,Wald ratio,1,1.05 [1-1.11],0.0554570847567831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1.05 [1-1.11],0.0556260513272678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HAVCR1,Hepatitis A virus cellular receptor 1,Wald ratio,1,1.04 [1-1.09],0.0562692986753424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HAVCR2,Hepatitis A virus cellular receptor 2,Wald ratio,1,1.05 [1-1.11],0.0580065073573648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,1.05 [1-1.12],0.0615955719675989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FGFBP1,Fibroblast growth factor-binding protein 1,Wald ratio,1,0.95 [0.9-1],0.0625360988479856,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,THBD,Thrombomodulin,Wald ratio,1,1.05 [1-1.11],0.0626929423971655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FAM3B,Protein FAM3B,Wald ratio,1,1.05 [1-1.1],0.0630604189806482,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,OLR1,Oxidized low-density lipoprotein receptor 1,Wald ratio,1,1.05 [1-1.11],0.0645691916541928,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,B2M,Beta-2-microglobulin,Wald ratio,1,1.05 [1-1.11],0.0651108724296838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.05 [1-1.1],0.0657647508028772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,B4GALT1,"Beta-1,4-galactosyltransferase 1",Wald ratio,1,1.05 [1-1.11],0.0672457067427055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CTSL,Cathepsin L1,Wald ratio,1,1.05 [1-1.11],0.0677472765024792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Wald ratio,1,1.05 [1-1.1],0.0693858852314156,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD300C,CMRF35-like molecule 6,Wald ratio,1,1.05 [1-1.1],0.0697358413677324,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COL4A1,Collagen alpha-1(IV) chain,Wald ratio,1,1.05 [0.99-1.11],0.0802583104700311,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LGALS9,Galectin-9,Wald ratio,1,1.04 [0.99-1.1],0.0813117434072169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CHI3L1,Chitinase-3-like protein 1,Wald ratio,1,1.04 [0.99-1.09],0.086581055068689,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FOLR1,Folate receptor alpha,Wald ratio,1,1.05 [0.99-1.1],0.0874051513656242,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SLAMF1,Signaling lymphocytic activation molecule,Wald ratio,1,1.05 [0.99-1.11],0.0902883200062522,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GGT5,Glutathione hydrolase 5 proenzyme,Wald ratio,1,1.05 [0.99-1.1],0.0903229233234258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ESAM,Endothelial cell-selective adhesion molecule,Wald ratio,1,1.05 [0.99-1.1],0.0903907928774736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPHB6,Ephrin type-B receptor 6,Wald ratio,1,1.05 [0.99-1.11],0.0914292673807013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD274,Programmed cell death 1 ligand 1,Wald ratio,1,1.05 [0.99-1.1],0.0915725712228956,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VSIG4,V-set and immunoglobulin domain-containing protein 4,Wald ratio,1,1.05 [0.99-1.1],0.0924512340689186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GAST,Gastrin,Wald ratio,1,1.05 [0.99-1.1],0.093210046121748,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXCL17,C-X-C motif chemokine 17,Wald ratio,1,1.04 [0.99-1.09],0.0945116204243405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CRELD1,Protein disulfide isomerase CRELD1,Wald ratio,1,1.04 [0.99-1.09],0.0945140446633248,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Wald ratio,1,1.05 [0.99-1.1],0.0958456206652286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FABP3,"Fatty acid-binding protein, heart",Wald ratio,1,1.04 [0.99-1.1],0.0961154068434584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SNRPB2,U2 small nuclear ribonucleoprotein B'',Wald ratio,1,1.05 [0.99-1.1],0.096731866251253,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPINK1,Serine protease inhibitor Kazal-type 1,Wald ratio,1,1.04 [0.99-1.1],0.0985784762897644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ASGR2,Asialoglycoprotein receptor 2,Wald ratio,1,1.04 [0.99-1.1],0.104087733371976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RETN,Resistin,Wald ratio,1,1.04 [0.99-1.1],0.109704529170672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LRRC25,Leucine-rich repeat-containing protein 25,Wald ratio,1,1.04 [0.99-1.1],0.11010259236007,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPINT2,Kunitz-type protease inhibitor 2,Wald ratio,1,1.04 [0.99-1.1],0.113063536976262,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RSPO3,R-spondin-3,Wald ratio,1,0.96 [0.91-1.01],0.113483788525563,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD300A,CMRF35-like molecule 8,Wald ratio,1,1.04 [0.99-1.1],0.114309527178531,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL12B,Interleukin-12 subunit beta,Wald ratio,1,0.96 [0.92-1.01],0.116586873188063,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Wald ratio,1,1.04 [0.99-1.09],0.119859524076549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VCAM1,Vascular cell adhesion protein 1,Wald ratio,1,1.04 [0.99-1.1],0.121590202411289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Wald ratio,1,1.04 [0.99-1.1],0.122778350140843,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.96 [0.91-1.01],0.124283694454335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.04 [0.99-1.1],0.125646924602257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PDIA3,Protein disulfide-isomerase A3,Wald ratio,1,1.04 [0.99-1.1],0.125934737272577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.04 [0.99-1.1],0.1266415448025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACP5,Tartrate-resistant acid phosphatase type 5,Wald ratio,1,1.04 [0.99-1.09],0.127150811293901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VWC2,Brorin,Wald ratio,1,0.96 [0.92-1.01],0.128132773623266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Wald ratio,1,1.03 [0.99-1.08],0.128701157301757,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ITGAV,Integrin alpha-V,Wald ratio,1,1.04 [0.99-1.1],0.129917387767368,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL23,C-C motif chemokine 23,Wald ratio,1,1.04 [0.99-1.09],0.131202592827965,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TFF3,Trefoil factor 3,Wald ratio,1,0.96 [0.91-1.01],0.132297774100979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GFRA1,GDNF family receptor alpha-1,Wald ratio,1,0.96 [0.91-1.01],0.133125832477116,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIGLEC1,Sialoadhesin,Wald ratio,1,1.04 [0.99-1.09],0.135993627840994,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LRP11,Low-density lipoprotein receptor-related protein 11,Wald ratio,1,1.04 [0.99-1.1],0.136853301755078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FGFR2,Fibroblast growth factor receptor 2,Wald ratio,1,1.04 [0.99-1.09],0.136877994963606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CRHBP,Corticotropin-releasing factor-binding protein,Wald ratio,1,1.04 [0.99-1.09],0.137286957340512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL10RB,Interleukin-10 receptor subunit beta,Wald ratio,1,1.04 [0.99-1.09],0.137461083695166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL12RB1,Interleukin-12 receptor subunit beta-1,Wald ratio,1,1.04 [0.99-1.1],0.137499252253439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CHGB,Secretogranin-1,Wald ratio,1,0.96 [0.92-1.01],0.13861099052844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HPGDS,Hematopoietic prostaglandin D synthase,Wald ratio,1,1.04 [0.99-1.09],0.143219288592285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ITGA5,Integrin alpha-5,Wald ratio,1,1.04 [0.99-1.1],0.14714384320568,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD4,T-cell surface glycoprotein CD4,Wald ratio,1,1.04 [0.99-1.1],0.149438627867689,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PCSK9,Proprotein convertase subtilisin/kexin type 9,Wald ratio,1,0.96 [0.91-1.01],0.149618804922211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CRIM1,Cysteine-rich motor neuron 1 protein,Wald ratio,1,1.04 [0.99-1.1],0.151354758564192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FGF21,Fibroblast growth factor 21,Wald ratio,1,1.04 [0.99-1.1],0.154339605986477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADGRG1,Adhesion G-protein coupled receptor G1,Wald ratio,1,1.04 [0.99-1.09],0.154948418920124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LRG1,Leucine-rich alpha-2-glycoprotein,Wald ratio,1,1.04 [0.99-1.09],0.155018840559549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NPPB,Natriuretic peptides B,Wald ratio,1,1.04 [0.99-1.1],0.155446352164032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Wald ratio,1,1.03 [0.99-1.09],0.155950356836561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,THBS2,Thrombospondin-2,Wald ratio,1,1.04 [0.99-1.1],0.156837882229217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Wald ratio,1,1.04 [0.99-1.09],0.15714562849122,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Wald ratio,1,1.04 [0.98-1.1],0.15983112865043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PGLYRP1,Peptidoglycan recognition protein 1,Wald ratio,1,1.04 [0.98-1.1],0.161327502210548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Wald ratio,1,0.96 [0.92-1.01],0.162294701549943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MSR1,Macrophage scavenger receptor types I and II,Wald ratio,1,1.03 [0.99-1.09],0.168445162312713,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SELE,E-selectin,Wald ratio,1,1.03 [0.99-1.08],0.169178232298007,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.04 [0.98-1.1],0.17086218910678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CDCP1,CUB domain-containing protein 1,Wald ratio,1,1.03 [0.99-1.08],0.171140988426117,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TFPI2,Tissue factor pathway inhibitor 2,Wald ratio,1,1.04 [0.98-1.09],0.174616241746608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL17C,Interleukin-17C,Wald ratio,1,0.96 [0.91-1.02],0.177158130808767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADAMTSL2,ADAMTS-like protein 2,Wald ratio,1,1.04 [0.98-1.1],0.178634859825043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Wald ratio,1,1.03 [0.98-1.08],0.179371755862866,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LAYN,Layilin,Wald ratio,1,1.03 [0.98-1.09],0.181170876035145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCG2,Secretogranin-2,Wald ratio,1,0.96 [0.91-1.02],0.183801481817275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.97 [0.92-1.02],0.183949453262763,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LAMA4,Laminin subunit alpha-4,Wald ratio,1,0.96 [0.91-1.02],0.184162388871087,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DTNB,Dystrobrevin beta,Wald ratio,1,0.97 [0.92-1.02],0.184970002272229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FGF23,Fibroblast growth factor 23,Wald ratio,1,0.96 [0.91-1.02],0.185667327001407,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EGFL7,Epidermal growth factor-like protein 7,Wald ratio,1,1.04 [0.98-1.09],0.186391119664633,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,APOM,Apolipoprotein M,Wald ratio,1,0.96 [0.91-1.02],0.186954360854427,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCARF2,Scavenger receptor class F member 2,Wald ratio,1,1.03 [0.98-1.08],0.189523514767357,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Wald ratio,1,1.03 [0.98-1.09],0.190860942480726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CTSS,Cathepsin S,Wald ratio,1,1.04 [0.98-1.1],0.190987392226496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC4D,C-type lectin domain family 4 member D,Wald ratio,1,1.03 [0.98-1.09],0.191180433286847,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,0.97 [0.92-1.02],0.192166286692378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD7,T-cell antigen CD7,Wald ratio,1,1.03 [0.98-1.09],0.196837325113365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NECTIN4,Nectin-4,Wald ratio,1,1.04 [0.98-1.09],0.19690822255976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD59,CD59 glycoprotein,Wald ratio,1,1.03 [0.98-1.09],0.199075484144947,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL15,Interleukin-15,Wald ratio,1,0.97 [0.91-1.02],0.200628775379393,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.03 [0.98-1.09],0.201534314797057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MMP8,Neutrophil collagenase,Wald ratio,1,1.03 [0.98-1.09],0.2042039798625,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFSF14,Tumor necrosis factor ligand superfamily member 14,Wald ratio,1,1.04 [0.98-1.09],0.206180460837429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AGRN,Agrin,Wald ratio,1,1.03 [0.98-1.09],0.210272582268067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL7,C-C motif chemokine 7,Wald ratio,1,1.03 [0.98-1.09],0.211698169418333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TGOLN2,Trans-Golgi network integral membrane protein 2,Wald ratio,1,1.03 [0.98-1.08],0.212892516034288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FAM3C,Protein FAM3C,Wald ratio,1,1.03 [0.98-1.09],0.21552774980761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PLXNB2,Plexin-B2,Wald ratio,1,1.03 [0.98-1.08],0.216004421326261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CA9,Carbonic anhydrase 9,Wald ratio,1,1.03 [0.98-1.09],0.216613661001161,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC6A,C-type lectin domain family 6 member A,Wald ratio,1,1.03 [0.98-1.09],0.217099683561148,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ELN,Elastin,Wald ratio,1,1.03 [0.98-1.07],0.219603388893101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Wald ratio,1,1.03 [0.98-1.09],0.221100255731358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Wald ratio,1,1.03 [0.98-1.09],0.221289797374113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Wald ratio,1,0.97 [0.92-1.02],0.224491436659329,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COL5A1,Collagen alpha-1(V) chain,Wald ratio,1,1.03 [0.98-1.09],0.22449736064618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SULT2A1,Bile salt sulfotransferase,Wald ratio,1,1.03 [0.98-1.09],0.227180817235905,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.97 [0.92-1.02],0.227473491094099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGSF3,Immunoglobulin superfamily member 3,Wald ratio,1,1.03 [0.98-1.09],0.229340635966355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VEGFA,Vascular endothelial growth factor A,Wald ratio,1,1.03 [0.98-1.09],0.232004403428401,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Wald ratio,1,1.03 [0.98-1.09],0.236211415815438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SMOC1,SPARC-related modular calcium-binding protein 1,Wald ratio,1,0.97 [0.92-1.02],0.237305153902536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACE2,Angiotensin-converting enzyme 2,Wald ratio,1,1.03 [0.98-1.08],0.23787606711779,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD302,CD302 antigen,Wald ratio,1,1.03 [0.98-1.09],0.241538567870296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Wald ratio,1,0.97 [0.92-1.02],0.241922457570253,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PON3,Serum paraoxonase/lactonase 3,Wald ratio,1,0.97 [0.92-1.02],0.246008433147247,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL18,Interleukin-18,Wald ratio,1,1.03 [0.98-1.09],0.247352604542957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COCH,Cochlin,Wald ratio,1,1.03 [0.98-1.08],0.247962812173645,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL10,Interleukin-10,Wald ratio,1,1.03 [0.98-1.09],0.251401119825133,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TGFBR2,TGF-beta receptor type-2,Wald ratio,1,1.03 [0.98-1.09],0.25492498227846,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.03 [0.98-1.09],0.262461139033679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Wald ratio,1,1.03 [0.98-1.09],0.263205931430982,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,0.97 [0.92-1.02],0.266347427109503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NRP1,Neuropilin-1,Wald ratio,1,1.03 [0.98-1.08],0.269053888363447,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ULBP2,UL16-binding protein 2,Wald ratio,1,1.03 [0.98-1.09],0.278155823753755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCDC80,Coiled-coil domain-containing protein 80,Wald ratio,1,0.97 [0.93-1.02],0.278995777443157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL14,C-C motif chemokine 14,Wald ratio,1,1.03 [0.98-1.08],0.280427514120721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NHLRC3,NHL repeat-containing protein 3,Wald ratio,1,1.03 [0.98-1.09],0.281308933063923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Wald ratio,1,1.03 [0.98-1.08],0.281956006498669,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.97 [0.92-1.02],0.282071130510155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL27,C-C motif chemokine 27,Wald ratio,1,1.03 [0.98-1.08],0.290007414641827,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCN3,CCN family member 3,Wald ratio,1,1.03 [0.98-1.08],0.291928359409654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CRELD2,Protein disulfide isomerase CRELD2,Wald ratio,1,1.03 [0.98-1.08],0.293576463526742,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Wald ratio,1,1.03 [0.98-1.08],0.296059564009007,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,STC1,Stanniocalcin-1,Wald ratio,1,0.97 [0.92-1.03],0.296735686658902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,1.03 [0.98-1.08],0.30448859711453,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPON1,Spondin-1,Wald ratio,1,1.03 [0.98-1.08],0.305272440713213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGFBP7,Insulin-like growth factor-binding protein 7,Wald ratio,1,0.97 [0.93-1.02],0.30627342680698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Wald ratio,1,0.97 [0.93-1.02],0.306691708313274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXCL11,C-X-C motif chemokine 11,Wald ratio,1,1.03 [0.97-1.08],0.308852075458328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CST3,Cystatin-C,Wald ratio,1,1.03 [0.98-1.08],0.310271768648001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SMPD1,Sphingomyelin phosphodiesterase,Wald ratio,1,0.97 [0.93-1.02],0.313454352367854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC3B,Tetranectin,Wald ratio,1,0.97 [0.92-1.03],0.31415847274978,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PRSS2,Trypsin-2,Wald ratio,1,0.97 [0.92-1.03],0.314528074174775,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MRC1,Macrophage mannose receptor 1,Wald ratio,1,1.03 [0.98-1.08],0.315732070966724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NECTIN2,Nectin-2,Wald ratio,1,1.03 [0.97-1.08],0.316490811409322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,1.03 [0.97-1.08],0.317097945973187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Wald ratio,1,1.03 [0.98-1.08],0.318181155148638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Wald ratio,1,1.03 [0.98-1.08],0.321581241274675,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD276,CD276 antigen,Wald ratio,1,0.98 [0.94-1.02],0.322323193997303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL1RN,Interleukin-1 receptor antagonist protein,Wald ratio,1,1.03 [0.97-1.08],0.324762613773611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Wald ratio,1,1.03 [0.97-1.08],0.325945191437534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,1.03 [0.97-1.08],0.327308743348676,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXCL9,C-X-C motif chemokine 9,Wald ratio,1,1.03 [0.98-1.08],0.329081946272912,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FGL1,Fibrinogen-like protein 1,Wald ratio,1,0.98 [0.94-1.02],0.3317576846431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,0.97 [0.92-1.03],0.332001801483811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ANGPT2,Angiopoietin-2,Wald ratio,1,0.97 [0.92-1.03],0.335085961781594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PALM2,Paralemmin-2,Wald ratio,1,1.03 [0.97-1.08],0.335444120612975,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ATRAID,All-trans retinoic acid-induced differentiation factor,Wald ratio,1,1.03 [0.97-1.08],0.336249622351452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SDC1,Syndecan-1,Wald ratio,1,1.03 [0.97-1.08],0.338231905222665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EFNA1,Ephrin-A1,Wald ratio,1,0.97 [0.92-1.03],0.34107152826979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PRG2,Bone marrow proteoglycan,Wald ratio,1,1.03 [0.97-1.08],0.346547895799121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL4,C-C motif chemokine 4,Wald ratio,1,0.98 [0.93-1.03],0.347881024408359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,Wald ratio,1,1.03 [0.97-1.08],0.348274840975334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,C7,Complement component C7,Wald ratio,1,1.02 [0.97-1.07],0.348532186528987,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD46,Membrane cofactor protein,Wald ratio,1,1.03 [0.97-1.08],0.349083501145449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,INSL5,Insulin-like peptide INSL5,Wald ratio,1,0.98 [0.93-1.03],0.349369499004917,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CALCA,Calcitonin,Wald ratio,1,1.02 [0.98-1.07],0.351359897182819,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PSAP,Prosaposin,Wald ratio,1,0.98 [0.93-1.03],0.351796530024168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PTX3,Pentraxin-related protein PTX3,Wald ratio,1,1.03 [0.97-1.08],0.353288295760288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BAMBI,BMP and activin membrane-bound inhibitor homolog,Wald ratio,1,1.03 [0.97-1.08],0.355234018117998,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CBLIF,Cobalamin binding intrinsic factor,Wald ratio,1,1.03 [0.97-1.08],0.357534675847109,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SORCS2,VPS10 domain-containing receptor SorCS2,Wald ratio,1,1.02 [0.97-1.08],0.362838168129987,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RNASE6,Ribonuclease K6,Wald ratio,1,1.02 [0.97-1.07],0.373023949095448,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FAS,Tumor necrosis factor receptor superfamily member 6,Wald ratio,1,1.02 [0.97-1.08],0.373749505212114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,REG1A,Lithostathine-1-alpha,Wald ratio,1,1.02 [0.97-1.08],0.377195957489913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HNMT,Histamine N-methyltransferase,Wald ratio,1,1.02 [0.97-1.07],0.379865200395664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Wald ratio,1,0.98 [0.92-1.03],0.385253048464107,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,UPB1,Beta-ureidopropionase,Wald ratio,1,1.02 [0.97-1.08],0.387484676299518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CBLN4,Cerebellin-4,Wald ratio,1,0.98 [0.93-1.03],0.388238382311501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DNER,Delta and Notch-like epidermal growth factor-related receptor,Wald ratio,1,0.98 [0.93-1.03],0.390264042951483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPHA2,Ephrin type-A receptor 2,Wald ratio,1,1.02 [0.97-1.08],0.396020279201283,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RELT,Tumor necrosis factor receptor superfamily member 19L,Wald ratio,1,1.02 [0.97-1.07],0.398691447859616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MANSC1,MANSC domain-containing protein 1,Wald ratio,1,1.02 [0.97-1.08],0.399627880543108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SEMA3F,Semaphorin-3F,Wald ratio,1,1.02 [0.97-1.08],0.403215489180068,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RBP2,Retinol-binding protein 2,Wald ratio,1,1.02 [0.97-1.08],0.405941463404734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,0.98 [0.92-1.03],0.409282330272494,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD83,CD83 antigen,Wald ratio,1,1.02 [0.97-1.08],0.409364633278119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SERPINA3,Alpha-1-antichymotrypsin,Wald ratio,1,1.02 [0.97-1.08],0.410468425680277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NUCB2,Nucleobindin-2,Wald ratio,1,1.02 [0.97-1.08],0.416383401804841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CFC1,Cryptic protein,Wald ratio,1,1.02 [0.97-1.08],0.418300309353848,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL6ST,Interleukin-6 receptor subunit beta,Wald ratio,1,1.02 [0.97-1.08],0.419341179419487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD99L2,CD99 antigen-like protein 2,Wald ratio,1,0.98 [0.93-1.03],0.421561504905711,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LGALS4,Galectin-4,Wald ratio,1,1.02 [0.97-1.07],0.431868710896484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.98 [0.93-1.03],0.432108335020305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Wald ratio,1,1.02 [0.97-1.08],0.43479301289942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CA12,Carbonic anhydrase 12,Wald ratio,1,1.02 [0.97-1.08],0.440227686683837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RBP5,Retinol-binding protein 5,Wald ratio,1,1.02 [0.97-1.07],0.441244451298397,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,WNT9A,Protein Wnt-9a,Wald ratio,1,1.02 [0.97-1.07],0.443491658757418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CPM,Carboxypeptidase M,Wald ratio,1,0.98 [0.93-1.03],0.444492188213052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Wald ratio,1,0.98 [0.93-1.03],0.449358361915196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TFF1,Trefoil factor 1,Wald ratio,1,1.02 [0.97-1.07],0.450101317476531,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Wald ratio,1,1.02 [0.97-1.08],0.451030058175602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CSTB,Cystatin-B,Wald ratio,1,1.02 [0.97-1.07],0.451612232639907,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NT5C1A,Cytosolic 5'-nucleotidase 1A,Wald ratio,1,1.02 [0.97-1.07],0.451867717652809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LEP,Leptin,Wald ratio,1,0.98 [0.94-1.03],0.452769039476879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RTN4R,Reticulon-4 receptor,Wald ratio,1,1.02 [0.97-1.07],0.452839680979454,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SHISA5,Protein shisa-5,Wald ratio,1,1.02 [0.97-1.07],0.454639848473393,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Wald ratio,1,1.02 [0.97-1.08],0.454969690265658,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ITGBL1,Integrin beta-like protein 1,Wald ratio,1,1.02 [0.97-1.07],0.455424711139037,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COLEC12,Collectin-12,Wald ratio,1,1.02 [0.97-1.07],0.456521603337403,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,KRT8,"Keratin, type II cytoskeletal 8",Wald ratio,1,0.98 [0.93-1.04],0.457506943914048,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GFER,FAD-linked sulfhydryl oxidase ALR,Wald ratio,1,1.02 [0.97-1.08],0.457880491962187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ASGR1,Asialoglycoprotein receptor 1,Wald ratio,1,1.02 [0.97-1.08],0.46221548352806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FCRLB,Fc receptor-like B,Wald ratio,1,1.02 [0.97-1.06],0.464988034366747,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GIPC2,PDZ domain-containing protein GIPC2,Wald ratio,1,1.02 [0.97-1.07],0.471215517332068,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD72,B-cell differentiation antigen CD72,Wald ratio,1,1.02 [0.97-1.08],0.471925261447817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Wald ratio,1,1.02 [0.97-1.06],0.476048623126664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TAFA5,Chemokine-like protein TAFA-5,Wald ratio,1,0.98 [0.93-1.03],0.480742984325887,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VMO1,Vitelline membrane outer layer protein 1 homolog,Wald ratio,1,1.01 [0.97-1.06],0.485373117471433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL16,C-C motif chemokine 16,Wald ratio,1,1.02 [0.97-1.06],0.487395453079955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MVK,Mevalonate kinase,Wald ratio,1,0.98 [0.93-1.04],0.489708499703169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL15,C-C motif chemokine 15,Wald ratio,1,1.02 [0.97-1.06],0.490463597892354,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,APOC1,Apolipoprotein C-I,Wald ratio,1,0.98 [0.93-1.03],0.490749346327355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,REG3A,Regenerating islet-derived protein 3-alpha,Wald ratio,1,1.02 [0.97-1.07],0.492244304270555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RNASE1,Ribonuclease pancreatic,Wald ratio,1,1.02 [0.97-1.07],0.49347049472809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MMP7,Matrilysin,Wald ratio,1,0.98 [0.93-1.03],0.494704703757926,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Wald ratio,1,0.98 [0.93-1.04],0.494870385437005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MMP9,Matrix metalloproteinase-9,Wald ratio,1,1.02 [0.97-1.07],0.501226321248376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CGREF1,Cell growth regulator with EF hand domain protein 1,Wald ratio,1,1.02 [0.97-1.07],0.5014703913499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TREM2,Triggering receptor expressed on myeloid cells 2,Wald ratio,1,1.02 [0.97-1.07],0.501625497512859,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",Wald ratio,1,1.02 [0.96-1.08],0.503827510113228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCLY,Selenocysteine lyase,Wald ratio,1,1.02 [0.97-1.07],0.505318064050449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Wald ratio,1,1.02 [0.97-1.07],0.507313814795619,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SOD2,"Superoxide dismutase [Mn], mitochondrial",Wald ratio,1,0.98 [0.93-1.04],0.512956731322053,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PI3,Elafin,Wald ratio,1,0.98 [0.93-1.03],0.513308586122966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BRK1,Protein BRICK1,Wald ratio,1,1.02 [0.96-1.08],0.520873318301821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,UMOD,Uromodulin,Wald ratio,1,1.01 [0.97-1.06],0.522032324078878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MMP3,Stromelysin-1,Wald ratio,1,0.99 [0.95-1.03],0.524849899429749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGF2R,Cation-independent mannose-6-phosphate receptor,Wald ratio,1,1.02 [0.96-1.07],0.530351747311347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,OCLN,Occludin,Wald ratio,1,1.02 [0.96-1.07],0.530617755329218,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CDH3,Cadherin-3,Wald ratio,1,1.02 [0.96-1.07],0.533242421690356,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACY1,Aminoacylase-1,Wald ratio,1,1.02 [0.97-1.07],0.533744010387014,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCRG1,Scrapie-responsive protein 1,Wald ratio,1,1.01 [0.97-1.06],0.548258527310781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXADR,Coxsackievirus and adenovirus receptor,Wald ratio,1,1.02 [0.96-1.07],0.549565991793135,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TMSB10,Thymosin beta-10,Wald ratio,1,1.02 [0.96-1.07],0.550440595209809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL20,C-C motif chemokine 20,Wald ratio,1,1.02 [0.96-1.07],0.551567752189744,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,C19orf12,Protein C19orf12,Wald ratio,1,1.02 [0.96-1.07],0.55275340748295,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACVRL1,Serine/threonine-protein kinase receptor R3,Wald ratio,1,1.02 [0.96-1.07],0.557471877942861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HGF,Hepatocyte growth factor,Wald ratio,1,1.02 [0.96-1.07],0.561894285577168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SRPX,Sushi repeat-containing protein SRPX,Wald ratio,1,1.02 [0.97-1.07],0.562422229278208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGFBP2,Insulin-like growth factor-binding protein 2,Wald ratio,1,0.98 [0.93-1.04],0.568541581104122,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NTRK3,NT-3 growth factor receptor,Wald ratio,1,0.98 [0.93-1.04],0.571705576335467,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GDF15,Growth/differentiation factor 15,Wald ratio,1,1.01 [0.97-1.06],0.573913888102041,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HYOU1,Hypoxia up-regulated protein 1,Wald ratio,1,1.02 [0.96-1.07],0.574994681751305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL21,C-C motif chemokine 21,Wald ratio,1,1.02 [0.96-1.07],0.578154057153347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BST2,Bone marrow stromal antigen 2,Wald ratio,1,1.02 [0.96-1.07],0.579778432711071,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LRRN1,Leucine-rich repeat neuronal protein 1,Wald ratio,1,0.99 [0.94-1.03],0.580020940502868,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CALB1,Calbindin,Wald ratio,1,0.99 [0.93-1.04],0.582118149578705,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HSPA2,Heat shock-related 70 kDa protein 2,Wald ratio,1,1.01 [0.96-1.07],0.590022119721957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,1.02 [0.96-1.07],0.592854271266769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,WFDC2,WAP four-disulfide core domain protein 2,Wald ratio,1,1.01 [0.96-1.07],0.59299628246571,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Wald ratio,1,1.01 [0.97-1.06],0.595972289692697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD34,Hematopoietic progenitor cell antigen CD34,Wald ratio,1,0.99 [0.93-1.04],0.596846873860158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LMNB2,Lamin-B2,Wald ratio,1,1.01 [0.96-1.07],0.600519956309383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPON2,Spondin-2,Wald ratio,1,1.01 [0.96-1.07],0.600635887762192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXCL16,C-X-C motif chemokine 16,Wald ratio,1,1.01 [0.96-1.07],0.602516347576652,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CKAP4,Cytoskeleton-associated protein 4,Wald ratio,1,1.01 [0.96-1.07],0.61543638145247,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL4R,Interleukin-4 receptor subunit alpha,Wald ratio,1,0.99 [0.94-1.04],0.615711650353344,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL18,C-C motif chemokine 18,Wald ratio,1,1.01 [0.96-1.06],0.617066392343317,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MDK,Midkine,Wald ratio,1,0.99 [0.93-1.04],0.621205452226595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AGXT,Serine--pyruvate aminotransferase,Wald ratio,1,1.01 [0.96-1.07],0.621660472757693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL2RA,Interleukin-2 receptor subunit alpha,Wald ratio,1,1.01 [0.96-1.06],0.622553562349563,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGSF8,Immunoglobulin superfamily member 8,Wald ratio,1,1.01 [0.96-1.07],0.622848360456172,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGFBP6,Insulin-like growth factor-binding protein 6,Wald ratio,1,1.01 [0.97-1.06],0.623985488398295,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GGT1,Glutathione hydrolase 1 proenzyme,Wald ratio,1,1.01 [0.96-1.06],0.626702557077604,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IMMT,MICOS complex subunit MIC60,Wald ratio,1,1.01 [0.96-1.07],0.627080070535837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NELL1,Protein kinase C-binding protein NELL1,Wald ratio,1,0.99 [0.94-1.04],0.634264213230918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.01 [0.96-1.06],0.635331211883715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AREG,Amphiregulin,Wald ratio,1,0.99 [0.94-1.04],0.635886318573241,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GPKOW,G-patch domain and KOW motifs-containing protein,Wald ratio,1,0.99 [0.93-1.04],0.639168774811893,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LTBP2,Latent-transforming growth factor beta-binding protein 2,Wald ratio,1,1.01 [0.97-1.06],0.640491849293831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MB,Myoglobin,Wald ratio,1,1.01 [0.96-1.06],0.640586076932996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.01 [0.96-1.07],0.643002693161129,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GM2A,Ganglioside GM2 activator,Wald ratio,1,1.01 [0.96-1.06],0.645374677917328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Wald ratio,1,1.01 [0.96-1.07],0.650246831069156,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RSPO1,R-spondin-1,Wald ratio,1,0.99 [0.94-1.04],0.651268723488891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MMP12,Macrophage metalloelastase,Wald ratio,1,1.01 [0.96-1.06],0.653232306476352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL1RL1,Interleukin-1 receptor-like 1,Wald ratio,1,1.01 [0.97-1.05],0.65430707227227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADGRG2,Adhesion G-protein coupled receptor G2,Wald ratio,1,1.01 [0.96-1.06],0.654896273426252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PENK,Proenkephalin-A,Wald ratio,1,0.99 [0.94-1.04],0.659942614038361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LY6D,Lymphocyte antigen 6D,Wald ratio,1,1.01 [0.96-1.06],0.663258200391794,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.01 [0.96-1.06],0.668035830941726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGLC2,Immunoglobulin lambda constant 2,Wald ratio,1,1.01 [0.96-1.07],0.678066775021668,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GLA,Alpha-galactosidase A,Wald ratio,1,0.99 [0.94-1.04],0.680164550455921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,REG4,Regenerating islet-derived protein 4,Wald ratio,1,0.99 [0.94-1.04],0.691065614713113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,0.99 [0.94-1.05],0.692984531420266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,OGN,Mimecan,Wald ratio,1,1.01 [0.96-1.06],0.69529270857794,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,KLK11,Kallikrein-11,Wald ratio,1,1.01 [0.96-1.06],0.699367162763201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CA5A,"Carbonic anhydrase 5A, mitochondrial",Wald ratio,1,1.01 [0.96-1.06],0.700253785235072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Wald ratio,1,0.99 [0.94-1.04],0.700599574124584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FAP,Prolyl endopeptidase FAP,Wald ratio,1,0.99 [0.94-1.04],0.704234313743786,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EGFR,Epidermal growth factor receptor,Wald ratio,1,0.99 [0.94-1.04],0.705938794348992,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FCN1,Ficolin-1,Wald ratio,1,0.99 [0.94-1.04],0.706286510823118,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FOLR2,Folate receptor beta,Wald ratio,1,0.99 [0.94-1.04],0.707111140409584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DPT,Dermatopontin,Wald ratio,1,0.99 [0.94-1.04],0.707695565504232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD300E,CMRF35-like molecule 2,Wald ratio,1,1.01 [0.96-1.06],0.711454680006845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NPPC,C-type natriuretic peptide,Wald ratio,1,0.99 [0.94-1.04],0.71230124931106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PVR,Poliovirus receptor,Wald ratio,1,1.01 [0.96-1.05],0.715306201281655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PGF,Placenta growth factor,Wald ratio,1,0.99 [0.94-1.04],0.717482382129658,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RBFOX3,RNA binding protein fox-1 homolog 3,Wald ratio,1,0.99 [0.94-1.04],0.717824670607666,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SERPINB8,Serpin B8,Wald ratio,1,1.01 [0.96-1.05],0.717901080129205,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Wald ratio,1,0.99 [0.94-1.04],0.720654159876189,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RAB6A,Ras-related protein Rab-6A,Wald ratio,1,0.99 [0.94-1.04],0.726385027128321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VWA1,von Willebrand factor A domain-containing protein 1,Wald ratio,1,0.99 [0.94-1.04],0.727138301405649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Wald ratio,1,1.01 [0.96-1.06],0.730098677779925,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD28,T-cell-specific surface glycoprotein CD28,Wald ratio,1,1.01 [0.96-1.07],0.730631190783109,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FABP1,"Fatty acid-binding protein, liver",Wald ratio,1,1.01 [0.96-1.06],0.733577104634831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FSTL3,Follistatin-related protein 3,Wald ratio,1,1.01 [0.96-1.06],0.735257949636188,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL28,C-C motif chemokine 28,Wald ratio,1,1.01 [0.96-1.06],0.73919653524629,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.01 [0.96-1.06],0.748844374128147,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DDT,D-dopachrome decarboxylase,Wald ratio,1,1.01 [0.96-1.06],0.749133646652235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NOS3,"Nitric oxide synthase, endothelial",Wald ratio,1,1.01 [0.96-1.07],0.749525626601992,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TCN2,Transcobalamin-2,Wald ratio,1,1.01 [0.96-1.05],0.750627132643903,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Wald ratio,1,1.01 [0.96-1.06],0.752020493047764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SMOC2,SPARC-related modular calcium-binding protein 2,Wald ratio,1,0.99 [0.94-1.04],0.753234900405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PRSS8,Prostasin,Wald ratio,1,1.01 [0.96-1.06],0.754054662252655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,KLK4,Kallikrein-4,Wald ratio,1,0.99 [0.95-1.04],0.757910800050381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Wald ratio,1,0.99 [0.94-1.04],0.758797301082896,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GOLM2,Protein GOLM2,Wald ratio,1,0.99 [0.94-1.05],0.760838969075999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPHA1,Ephrin type-A receptor 1,Wald ratio,1,0.99 [0.94-1.04],0.761610882265709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EDN1,Endothelin-1,Wald ratio,1,1.01 [0.96-1.06],0.762249403562755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.01 [0.96-1.06],0.7666854900838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.01 [0.95-1.06],0.769397391004706,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SLAMF8,SLAM family member 8,Wald ratio,1,0.99 [0.94-1.04],0.770924254833943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NEFL,Neurofilament light polypeptide,Wald ratio,1,0.99 [0.95-1.04],0.771027445322128,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MTUS1,Microtubule-associated tumor suppressor 1,Wald ratio,1,1.01 [0.95-1.06],0.776648808657392,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PTGDS,Prostaglandin-H2 D-isomerase,Wald ratio,1,0.99 [0.94-1.05],0.77753548777261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GPR37,Prosaposin receptor GPR37,Wald ratio,1,0.99 [0.95-1.04],0.77801273100211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COL6A3,Collagen alpha-3(VI) chain,Wald ratio,1,0.99 [0.94-1.05],0.781448358754874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LGALS1,Galectin-1,Wald ratio,1,0.99 [0.94-1.05],0.781701178679611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RNASE4,Ribonuclease 4,Wald ratio,1,0.99 [0.94-1.05],0.783692401248077,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD1C,T-cell surface glycoprotein CD1c,Wald ratio,1,1.01 [0.96-1.06],0.790995205957085,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCARF1,Scavenger receptor class F member 1,Wald ratio,1,1.01 [0.96-1.06],0.792243453520923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GLO1,Lactoylglutathione lyase,Wald ratio,1,0.99 [0.94-1.05],0.792925726485682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LBP,Lipopolysaccharide-binding protein,Wald ratio,1,0.99 [0.95-1.04],0.793200319228425,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.01 [0.95-1.06],0.794796084112012,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADM,Pro-adrenomedullin,Wald ratio,1,0.99 [0.94-1.05],0.797559457705655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LIFR,Leukemia inhibitory factor receptor,Wald ratio,1,1.01 [0.95-1.06],0.805205711289756,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD40,Tumor necrosis factor receptor superfamily member 5,Wald ratio,1,0.99 [0.94-1.05],0.810884565945562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TGFA,Protransforming growth factor alpha,Wald ratio,1,0.99 [0.94-1.05],0.812889374476869,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ANGPTL2,Angiopoietin-related protein 2,Wald ratio,1,1.01 [0.95-1.06],0.817342244883918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CKB,Creatine kinase B-type,Wald ratio,1,0.99 [0.94-1.05],0.818240710504975,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,INHBB,Inhibin beta B chain,Wald ratio,1,0.99 [0.94-1.05],0.818934304059486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIAE,Sialate O-acetylesterase,Wald ratio,1,0.99 [0.94-1.05],0.824393540568423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FUOM,Fucose mutarotase,Wald ratio,1,0.99 [0.94-1.05],0.827463637916735,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Wald ratio,1,1.01 [0.96-1.05],0.827605276522334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL22,Interleukin-22,Wald ratio,1,0.99 [0.94-1.05],0.828676595909691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Wald ratio,1,1.01 [0.95-1.06],0.829603020802216,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MUC13,Mucin-13,Wald ratio,1,0.99 [0.94-1.05],0.834255438283238,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CHCHD6,MICOS complex subunit MIC25,Wald ratio,1,0.99 [0.94-1.05],0.835654704275189,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LETM1,Mitochondrial proton/calcium exchanger protein,Wald ratio,1,0.99 [0.94-1.05],0.836249788162728,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FBLN2,Fibulin-2,Wald ratio,1,1.01 [0.95-1.06],0.844345503601132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Wald ratio,1,1.01 [0.95-1.06],0.845035626917474,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PPL,Periplakin,Wald ratio,1,1.01 [0.95-1.06],0.846004166977601,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL19,Interleukin-19,Wald ratio,1,0.99 [0.94-1.05],0.846076436096206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Wald ratio,1,1.01 [0.95-1.06],0.847250342276864,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,OSM,Oncostatin-M,Wald ratio,1,0.99 [0.94-1.05],0.848764577746477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPINK4,Serine protease inhibitor Kazal-type 4,Wald ratio,1,1 [0.96-1.05],0.84900502524332,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DKK4,Dickkopf-related protein 4,Wald ratio,1,1.01 [0.95-1.06],0.851366918675862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TIMP4,Metalloproteinase inhibitor 4,Wald ratio,1,1 [0.95-1.05],0.852192142145201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1 [0.95-1.06],0.854386545273859,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RBP7,Retinoid-binding protein 7,Wald ratio,1,1 [0.95-1.06],0.85452841805474,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NPC2,NPC intracellular cholesterol transporter 2,Wald ratio,1,1 [0.95-1.06],0.857156135370533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Wald ratio,1,1 [0.95-1.05],0.857549367886804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LTBP3,Latent-transforming growth factor beta-binding protein 3,Wald ratio,1,1 [0.96-1.06],0.860156050686431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TPP1,Tripeptidyl-peptidase 1,Wald ratio,1,1 [0.95-1.06],0.864273713898135,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RNASET2,Ribonuclease T2,Wald ratio,1,1 [0.94-1.05],0.86485368926548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ANG,Angiogenin,Wald ratio,1,1 [0.95-1.04],0.866302527400672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Wald ratio,1,1 [0.94-1.05],0.869628055994684,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,STC2,Stanniocalcin-2,Wald ratio,1,1 [0.95-1.06],0.869902461866214,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1 [0.95-1.06],0.870381203179446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,1 [0.94-1.05],0.872260376167829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Wald ratio,1,1 [0.96-1.06],0.872264181622384,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LGALS3,Galectin-3,Wald ratio,1,1 [0.95-1.04],0.874829055653169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLMP,CXADR-like membrane protein,Wald ratio,1,1 [0.96-1.05],0.875781642273515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NCS1,Neuronal calcium sensor 1,Wald ratio,1,1 [0.96-1.05],0.87739120216053,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HAO1,Hydroxyacid oxidase 1,Wald ratio,1,1 [0.95-1.06],0.880005438566088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IFNL1,Interferon lambda-1,Wald ratio,1,1 [0.95-1.06],0.880644730425535,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCN4,CCN family member 4,Wald ratio,1,1 [0.96-1.05],0.884284780416965,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CFD,Complement factor D,Wald ratio,1,1 [0.95-1.06],0.886438358038019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EDA2R,Tumor necrosis factor receptor superfamily member 27,Wald ratio,1,1 [0.96-1.05],0.890040835303052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LBR,Delta(14)-sterol reductase LBR,Wald ratio,1,1 [0.94-1.05],0.891333439590295,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LGALS3BP,Galectin-3-binding protein,Wald ratio,1,1 [0.95-1.05],0.892573516111481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MERTK,Tyrosine-protein kinase Mer,Wald ratio,1,1 [0.95-1.06],0.893108393864006,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",Wald ratio,1,1 [0.94-1.05],0.894796970212628,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Wald ratio,1,1 [0.96-1.05],0.897049665098949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNXB,Tenascin-X,Wald ratio,1,1 [0.94-1.05],0.898096909116546,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TGFB1,Transforming growth factor beta-1 proprotein,Wald ratio,1,1 [0.95-1.06],0.902317604681666,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TXNDC5,Thioredoxin domain-containing protein 5,Wald ratio,1,1 [0.95-1.06],0.902895359065376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,C1QA,Complement C1q subcomponent subunit A,Wald ratio,1,1 [0.95-1.06],0.909727555392734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MFAP4,Microfibril-associated glycoprotein 4,Wald ratio,1,1 [0.95-1.06],0.910293714371151,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Wald ratio,1,1 [0.95-1.05],0.91492238985847,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADA2,Adenosine deaminase 2,Wald ratio,1,1 [0.95-1.05],0.919919290849247,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NFASC,Neurofascin,Wald ratio,1,1 [0.95-1.05],0.920668072181268,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SNCG,Gamma-synuclein,Wald ratio,1,1 [0.96-1.04],0.923680560270136,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,REG1B,Lithostathine-1-beta,Wald ratio,1,1 [0.95-1.06],0.92438431680059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GRN,Progranulin,Wald ratio,1,1 [0.95-1.05],0.925561759209081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,Wald ratio,1,1 [0.94-1.05],0.925733357397056,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL18R1,Interleukin-18 receptor 1,Wald ratio,1,1 [0.96-1.05],0.926275439296322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1 [0.95-1.05],0.927198330707193,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ITGA11,Integrin alpha-11,Wald ratio,1,1 [0.95-1.05],0.927900774417106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,POF1B,Protein POF1B,Wald ratio,1,1 [0.94-1.05],0.93344835049051,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC1A,C-type lectin domain family 1 member A,Wald ratio,1,1 [0.95-1.05],0.933933705108472,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Wald ratio,1,1 [0.95-1.05],0.935495341331582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NPDC1,Neural proliferation differentiation and control protein 1,Wald ratio,1,1 [0.95-1.05],0.936224166052372,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,JAM2,Junctional adhesion molecule B,Wald ratio,1,1 [0.95-1.05],0.944568340581443,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,F9,Coagulation factor IX,Wald ratio,1,1 [0.95-1.05],0.945605513213113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FSTL1,Follistatin-related protein 1,Wald ratio,1,1 [0.95-1.06],0.945704734792588,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1 [0.95-1.05],0.946207108977672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Wald ratio,1,1 [0.95-1.05],0.948860614848854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PRAP1,Proline-rich acidic protein 1,Wald ratio,1,1 [0.95-1.05],0.950248343302427,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCN5,CCN family member 5,Wald ratio,1,1 [0.95-1.05],0.955097391739298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CFI,Complement factor I,Wald ratio,1,1 [0.95-1.06],0.966833707271906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CTSZ,Cathepsin Z,Wald ratio,1,1 [0.95-1.05],0.968456299974587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TCOF1,Treacle protein,Wald ratio,1,1 [0.95-1.06],0.970381451894028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FAM20A,Pseudokinase FAM20A,Wald ratio,1,1 [0.95-1.05],0.970876036999543,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL3,C-C motif chemokine 3,Wald ratio,1,1 [0.95-1.05],0.971197284635497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RARRES2,Retinoic acid receptor responder protein 2,Wald ratio,1,1 [0.95-1.06],0.973710411805211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CPXM2,Inactive carboxypeptidase-like protein X2,Wald ratio,1,1 [0.95-1.05],0.978639248617027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COL18A1,Collagen alpha-1(XVIII) chain,Wald ratio,1,1 [0.95-1.05],0.980204697230232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PTH,Parathyroid hormone,Wald ratio,1,1 [0.95-1.05],0.981335279006833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FABP5,Fatty acid-binding protein 5,Wald ratio,1,1 [0.95-1.06],0.987842133534288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Wald ratio,1,1 [0.95-1.06],0.99176963794106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DPY30,Protein dpy-30 homolog,Wald ratio,1,1 [0.95-1.06],0.997797470446636,trans
